Eli Lilly Defeats Soldier's Cymbalta 'Brain Zap' Suit

Law360, New York (December 17, 2013, 4:21 PM EST) -- A South Carolina federal judge ruled Monday that Eli Lilly & Co. did not fail to adequately warn an Iraq War veteran that the antidepressant Cymbalta can cause so-called brain zaps and other withdrawal symptoms, finding that a stronger warning would not have altered his treatment.

U.S. District Judge Cameron McGowan Currie granted summary judgment to Eli Lilly in a lawsuit brought by plaintiff Scott Carnes, who claimed he suffered “sharp, painful zaps of electricity” in his head, nightmares and anger issues after quitting Cymbalta, and...
To view the full article, register now.




Case Information

Case Title

Carnes et al v. Eli Lilly and Company

Case Number



South Carolina

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability


Cameron McGowan Currie

Date Filed

March 5, 2013

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.